A based <i>Cistanche deserticola</i> polysaccharide functional-nanoparticle delivery system for effective oral vaccine to facilitate both systemic and mucosal immunity through enhancing oral delivery. [PDF]
He J +8 more
europepmc +1 more source
Cellular Mechanism and Key Insights in Allergen Immunotherapy for Allergic Rhinitis
ABSTRACT Allergic rhinitis (AR) arises from immune responses mediated by immunoglobulin E (IgE) to inhaled allergens, representing one of the most prevalent chronic conditions worldwide. Although AR may not be a serious ailment, it holds clinical relevance as it underpins numerous complications, serves as a major risk factor for suboptimal asthma ...
Zhe Wang +3 more
wiley +1 more source
Maternal transfer of oral vaccine induced anti-OspA antibodies protects <i>Peromyscus</i> spp. from tick-transmitted <i>Borrelia burgdorferi</i>. [PDF]
Azevedo JF +4 more
europepmc +1 more source
The Amur tiger, an endangered flagship species mainly found in the Russia Far East and Northeastern China, holds immense biological importance, and has been listed under the Convention on International Trade in Endangered Species of Wild Fauna and Flora (CITES).
Wei Xie +15 more
wiley +1 more source
Maltase 1 regulates DENV2 infection and life history in Aedes aegypti
Our study employed CRISPR/Cas9 to generate a MAL1 knockout strain of Aedes aegypti, demonstrating that the absence of MAL1 significantly suppresses DENV2 replication in the midgut and impairs viral transmission. The mutation also altered life‐history (hatching/pupation/emerging rates and sex‐specific survival), identifying MAL1 as a novel target for ...
Man‐Jin Li +5 more
wiley +1 more source
A novel oral vaccine delivery system for enhancing stability and immune protection: bacterium-like particle with functional coating. [PDF]
De X +11 more
europepmc +1 more source
Observation on effect of oral rotavirus living vaccine in community children
徐芳 +4 more
openalex +1 more source
Lung cancer remains Australia's leading cause of cancer death. With new screening and evolving therapies, equitable access and workforce readiness are essential. This review discusses current and emerging treatments for NSCLC in Australia, clinical trials underway, and future directions in delivering optimal, accessible care nationwide.
Lauren Julia Brown +7 more
wiley +1 more source
Draft genome of Aeromonas veronii DFR01, the inactivated bacterial agent in a fish oral vaccine against motile aeromonad septicemia. [PDF]
Argayosa AM +3 more
europepmc +1 more source

